INTRODUCTION:
Radioiodine (RAI) is used as a definitive therapy of hyperthyroidism due to toxic adenoma (TA) as well as toxic multinodular goiter (TMG).
Achievement of euthyroidism or hypothyroidism is defined as a successful therapy.
METHODS:
The study was conducted in 666 patients -484 with TA and 182 with TMG (85.58% of women), aged 56.19±13.88 years. We analyzed retrospectively hormonal and imaging findings (scintigraphy, ultrasonography), including isotopic results in subjects treated at Department of Nuclear Medicine and at Endocrinology Department during the eightyear period. The efficacy of RAI therapy has been assessed based on free thyroid hormones levels, measured 12 months after radioiodine administration.
RESULTS:
Mean concentrations of FT4 and FT3 and age did not differ significantly both groups. Patients with TA had lower thyroid mass and RAI 24-h uptake than subjects with TMG (p=0.0000). Administered therapeutic activities of RAI (MBq), calculated using Marinelli's formula, were smaller in subjects with TA (537.03±181.39 vs 614.13±147.22; p=0.0000) and the thyroid-absorbed doses of RAI (Gy) in such patients were greater (p=0.0000).
The cure of hyperthyroidism was significantly correlated in both groups with lower: thyroid mass, RAI 24-h uptake and concentrations of FT4 and FT3 before therapy No significant associations between successful therapy and: -patients' age /-thyroid absorbed dose / -used therapeutic activity of RAI were found. 
CONCLUSIONS

